News

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...
Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...
The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...
Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...
Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her ...
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...